Prognostic Impact of Tumor Size on pT2 Renal Cell Carcinoma: An International Multicenter Experience

Journal of Urology

Volumn 178, Issue 1, 2007, Pages 35-40

  Klatte, Tobias ^a   Patard, Jean Jacques ^b   Goel, Rakhee H ^a   Kleid, Mark D ^a   Guille, Francois ^b   Lobel, Bernard ^b   Abbou, Clement Claude ^c   De La Taille, Alexandre ^c   Tostain, Jacques ^d   Cindolo, Luca ^e   Altieri, Vincenzo ^e   Ficarra, Vincenzo ^f   Artibani, Walter ^f   Prayer Galetti, Tommaso ^f   Allhoff, Ernst Peter ^g   Schips, Luigi ^h   Zigeuner, Richard ^h   Figlin, Robert A ^a   Kabbinavar, Fairooz F ^a   Pantuck, Allan J ^a   Belldegrun, Arie S ^a   Lam, John S ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITÉ JEAN MONNET   (France)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

^h UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

classification; neoplasm metastasis; neoplasm staging; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 34250156007     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.046     Document Type: Article

References (19)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106
2. Zisman A., Pantuck A.J., Wieder J., Chao D.H., Dorey F., Said J.W., et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20 (2002) 4559
3. American Joint Committee on Cancer. Kidney. AJCC Cancer Staging Manual. 6th ed. (2002), Springe, New York 323-325
4. Delahunt B., Kittelson J.M., McCredie M.R., Reeve A.E., Stewart J.H., and Bilous A.M. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer 94 (2002) 658
5. Patard J.J., Dorey F.J., Cindolo L., Ficarra V., DeLaTaille A., Tostain J., et al. Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol 172 (2004) 2167
6. Frank I., Blute M.L., Leibovich B.C., Cheville J.C., Lohse C.M., Kwon E.D., et al. pT2 classification for renal cell carcinoma. Can its accuracy be improved?. J Urol 173 (2005) 380
7. Targonski P.V., Frank W., Stuhldreher D., and Guinan P.D. Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients. J Urol 152 (1994) 1389
8. Nativ O., Sabo E., Raviv G., Madjar S., Halachmi S., and Moskovitz B. The impact of tumor size on clinical outcome in patients with localized renal cell carcinoma treated by radical nephrectomy. J Urol 158 (1997) 729
9. Kovacs G., Akhtar M., Beckwith B.J., Bugert P., Cooper C.S., Delahunt B., et al. The Heidelberg classification of renal cell tumours. J Pathol 183 (1997) 131
10. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655
11. Bell E.T. A classification of renal tumors with observations on the frequency of the various types. J Urol 49 (1938) 238
12. Steiner T., Knels R., and Schubert J. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 46 (2004) 327
13. Gelb A.B. Renal cell carcinoma: current prognostic factors. Cancer 80 (1997) 981
14. Lam J.S., Shvarts O., Leppert J.T., Figlin R.A., and Belldegrun A.S. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173 (2005) 1853
15. Méjean A., Oudard S., and Thiounn N. Prognostic factors of renal cell carcinoma. J Urol 169 (2003) 821
16. Shvarts O., Seligson D., Lam J., Shi T., Horvath S., Figlin R., et al. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma. J Urol 173 (2005) 725
17. Atzpodien J., Schmitt E., Gertenbach U., Fornara P., Heynemann H., Maskow A., et al. Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Br J Cancer 92 (2005) 843
18. Clark J.I., Atkins M.B., Urba W.J., Creech S., Figlin R.A., Dutcher J.P., et al. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. J Clin Oncol 21 (2003) 3133
19. Messing E.M., Manola J., Wilding G., Propert K., Fleischmann J., Crawford E.D., et al. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. J Clin Oncol 21 (2003) 1214